Gas-Liquid Chromatography for Pharma QC in Hyderabad: Residual Solvents, Validation and Audit-Ready Setup

Walk through the QC laboratory of almost any bulk-drug unit in Jeedimetla, Pashamylaram, Patancheru or Genome Valley and you will find the same instrument on the same bench it has occupied for years: a gas chromatograph with a flame ionisation detector, a headspace sampler beside it, and a logbook that an auditor will ask for before asking for anything else.

Gas-liquid chromatography (GLC) is not the glamorous end of analytical science, but it is the technique on which release decisions for active pharmaceutical ingredients (APIs) routinely depend. When a batch of an intermediate carries too much residual toluene or methanol, nothing else in the dossier matters. The batch is held, the investigation opens, and the customer audit that follows will look at the instrument as closely as it looks at the result.

This guide is written for the people who carry that responsibility in Hyderabad: QC heads, analytical development managers, procurement leads and lab-setup teams at API manufacturers, formulation units and contract testing laboratories. It does not explain chromatography from first principles. Instead, it follows the question an inspector would put to you: can you demonstrate that this system is fit for the work you use it for, and do the records prove it? Along the way it covers how residual solvent testing is structured, what a defensible column and detector configuration looks like, where data integrity gaps tend to hide on older systems, and how to compare a certified refurbished GC with a new one on total cost rather than purchase price.

Gas-liquid chromatography separates volatile and thermally stable compounds by passing them, in a carrier gas, through a column whose inner surface carries a thin film of liquid stationary phase. Each compound spends a different share of its time dissolved in that liquid film and a different share travelling in the gas, so each emerges at its own retention time. A detector, most often a flame ionisation detector (FID), converts each emerging band into an electrical signal that the data system records as a peak.

Modern laboratories usually work with fused-silica capillary columns, where the liquid phase is bonded to the tube wall. Some older compendial methods still describe packed columns, in which the liquid phase is coated on a solid support. Both are GLC in the strict sense, and a Hyderabad lab that handles legacy monographs may need to run either.

In a pharmaceutical setting, GLC earns its place for several reasons:

•             Residual solvents in APIs and intermediates. Almost every synthetic route uses organic solvents, and almost every one has to be shown to be controlled in the final material.

•             Assay and purity of volatile compounds. Starting materials, reagents and some APIs are best assayed by GC.

•             Volatile related substances. Certain process impurities, such as alkyl halides, are volatile and are tracked by GC with an appropriate detector or by GC-MS.

•             Incoming solvent verification. Plants that buy solvents in tanker quantities test identity and purity before use, and also check for Class 1 contaminants such as benzene in toluene.

•             In-process control. Reaction monitoring by GC shortens cycle times and reduces rework.

•             Cleaning verification. Solvent traces on equipment surfaces can be checked by headspace GC between campaigns on multi-product lines.

Why not shift all of this to liquid chromatography? Because HPLC with UV detection cannot see many small solvent molecules at all, since they lack a chromophore, while the FID responds to virtually every organic compound that burns. It is also stable, wide in linear range and inexpensive to run per sample. For a Hyderabad plant running dozens of residual solvent checks per week, those characteristics matter far more than novelty.

The framework for residual solvents is the ICH Q3C guideline, which classifies solvents by toxicity and sets permitted daily exposure (PDE) limits. Pharmacopoeial chapters, including USP <467>, European Pharmacopoeia 2.4.24 and the Indian Pharmacopoeia, translate that framework into analytical procedures. Your customers, whether in the regulated markets of the US and Europe or in domestic formulation, will expect compliance with the current revision of ICH Q3C and the relevant compendial chapter.

These figures are the Option 1 concentration limits, which assume a daily dose of 10 g or less. Always verify limits against the current ICH Q3C revision and your product's daily dose before putting them in a specification, because Option 2 calculations based on the actual dose can allow different values.

What auditors tend to examine

An inspector reviewing your residual solvent testing generally follows a predictable path. First, they check that the list of solvents tested is derived from the actual manufacturing route, including solvents used in earlier steps that could carry through, and not copied from a generic template. Second, they look at whether the method is a compendial one that has been verified in your laboratory, or an in-house method that has been fully validated. Third, they open the raw data, including system suitability, chromatograms for blanks and standards, integration events and audit trails. Finally, they look at the instrument's qualification status and maintenance history.

Notice that three of those four steps are about the instrument and its records rather than the molecule. That is the central point of this guide: in a regulated Hyderabad lab, buying or commissioning a GLC system is a quality decision before it is a technical one.

The workhorse arrangement for residual solvents is static headspace sampling coupled to GC-FID. The sample is dissolved in a high-boiling diluent such as dimethyl sulfoxide, dimethylformamide or water, sealed in a vial and heated so that volatile solvents partition into the gas above the liquid. A portion of that headspace is injected onto the column. Because the non-volatile API stays behind in the vial, the inlet and column stay cleaner for longer than they would with direct liquid injection.

Compendial approaches typically use two columns of different selectivity. A mid-polarity phase containing roughly 6% cyanopropylphenyl and 94% dimethylpolysiloxane (the USP G43 designation, for example a 624-type column) is used for the primary procedure. A polyethylene glycol (wax) phase, USP G16, is used for confirmation when a peak is suspected or an out-of-limit result needs to be supported. A common dimension is 30 m by 0.32 mm internal diameter with a 1.8 µm film, though 0.53 mm columns are also seen.

System suitability is where methods are won or lost

Before any batch result is reported, the system must prove it is working on that day. System suitability criteria for residual solvent procedures generally include resolution between a defined critical pair of peaks, a minimum signal-to-noise ratio for a peak at or near the reporting limit, and repeatability of replicate standard injections expressed as relative standard deviation. These are not paperwork. They are the early warning for a worn liner, a leaking septum or a degrading column.

A system that struggles to meet signal-to-noise at the limit concentration for a Class 2 solvent usually has a mechanical cause that is easy to find if you look for it: a contaminated FID jet, an inlet leak, or a headspace needle that is partly blocked. Keep a short troubleshooting sequence in your SOP and train analysts to follow it before they repeat injections, because repeated injections without investigation are exactly what inspectors flag as testing into compliance.

Carrier gas and fuel gas decisions for Hyderabad plants

Helium is the traditional carrier gas for capillary GC, but supply and cost swings in recent years have led many Indian laboratories to validate methods with hydrogen or nitrogen. Hydrogen, usually produced by an on-site generator, gives fast analyses and good efficiency at higher flow, but it requires leak detection and sound ventilation practice. Nitrogen is safe and inexpensive but slower. Whichever you choose, a change of carrier gas on a validated method is a change that has to go through change control and, depending on the method, a verification or revalidation exercise. Decide your gas strategy before you finalise methods, not after.

An analytical instrument is qualified, and an analytical method is validated. Mixing those terms up in front of an auditor is a small mistake that suggests larger gaps, so it is worth being precise.

Instrument qualification

The lifecycle for a GC system normally runs through four stages, following the thinking in USP <1058> on analytical instrument qualification.

1.           Design qualification (DQ). A documented statement of what the instrument must do, for example which detectors, which sampler, which gas supply, how many samples per day, and which software controls it. DQ is the document that stops you from buying an instrument that fits a catalogue rather than your work.

2.           Installation qualification (IQ). Evidence that the system, including every module and accessory, was delivered and installed as specified: serial numbers, utilities, gas connections, software versions and a record of what was received.

3.           Operational qualification (OQ). Testing that the system operates within defined limits across its operating range. For a GC this normally includes oven temperature accuracy and stability, flow and pressure accuracy, detector noise, drift and sensitivity, injection precision, carryover and, where appropriate, detector linearity.

4.           Performance qualification (PQ). Demonstration that the system performs for its intended use with your actual method, standards and sample type, over a period representative of real use.

After qualification, the instrument enters a maintained state. That means scheduled preventive maintenance, periodic calibration of oven temperature and flows against traceable references, requalification after significant repairs or relocation, and a usage logbook that connects each run to an analyst, a method and a date.

Method validation and verification

For an in-house residual solvent method, validation follows ICH Q2, now in its R2 revision, and typically covers specificity, limit of detection and quantitation, linearity, accuracy (recovery from spiked samples), precision at repeatability and intermediate levels, and robustness. For a compendial procedure, the laboratory usually does not repeat full validation but must verify that the method works for its specific material, as described in USP <1226>. Verification should include checking that your API matrix does not interfere with solvent peaks and that recovery at the limit level is acceptable.

Practical point: Qualification of the instrument and validation of the method are linked. If you move a validated method to a new or refurbished GC, you should document how equivalence was demonstrated: system suitability results, retention times for the critical pair, and sensitivity at the limit level on the new system compared with the old.

The hardware of a gas chromatograph, meaning the oven, the electronic pneumatic control modules, the inlet and the detector, is robust and can run reliably for many years when maintained. The element that most often causes trouble in audits is the data system. Regulators expect records to be attributable, legible, contemporaneous, original and accurate, the ALCOA principles, extended in practice to complete, consistent, enduring and available (ALCOA+). For electronic records, 21 CFR Part 11 and equivalent expectations in EU and Indian GMP shape what the CDS must do.

The questions to ask before commissioning

•             Is the CDS version supported and validated? Software that runs only on an operating system the vendor no longer supports is a risk, both for security and for validation.

•             Are unique user logins and role-based access enforced? Shared accounts are among the most common observations in inspections.

•             Is the audit trail enabled, reviewable and protected from editing? It should record who changed what, when and why, including changes to integration events.

•             Is the system clock controlled? Analysts should not be able to change date and time, and the clock should be synchronised to a reference source.

•             How is data backed up and retained? Raw data and metadata must remain readable for the retention period, so migration plans for ageing computers matter.

•             Does the instrument communicate with the CDS reliably? Network cards and communication boards are common failure points on older units and should be tested, not assumed.

•             Are there written rules for manual integration? Reprocessing without a documented justification invites scrutiny.

Be realistic about who is responsible for what. A refurbisher can supply a GC with a documented condition, tested modules and a clean qualification package, but the compliant configuration of your CDS, the writing of your SOPs and the training of your analysts remain the laboratory's responsibility. A supplier who promises otherwise should be questioned. The right expectation is that the supplier hands over hardware with traceable records and that your quality unit completes the compliant configuration.

Recurring observations worth designing out

Across the industry, inspection findings related to chromatography follow familiar patterns: trial injections that are not recorded, injections deleted or sequences aborted without explanation, backups that are never restored as a test, and logbooks that do not reconcile with CDS sequences. Selecting a GC platform and CDS arrangement that make the compliant path the easy path is cheaper than remediating a finding later.

Capital budgets in the Hyderabad pharma cluster are real, and so are the delays that come with long import lead times. A certified refurbished GC from a reputable brand such as Agilent, Shimadzu, PerkinElmer or Thermo Fisher can be a sound choice, provided the decision is made on the right basis.

Costs that never appear on the quotation

Instrument price is only a part of what a GC costs to own. Budget for gas supply (cylinders, a generator or a manifold), consumables such as liners, septa, ferrules, FID jets and vials, columns that are replaced every few months in heavy use, a service contract or an in-house maintenance engineer, a UPS and voltage stabiliser sized for the oven and PC, and the time of the analysts who qualify the system. Hyderabad's hot summers also place a load on laboratory air conditioning, and ovens that cannot cool quickly between runs lengthen cycle times. Plan the room, not just the instrument.

A fair comparison asks what it costs to produce one reported result over five years, including downtime. On that basis, a refurbished system that is well documented and supported locally often compares favourably, and a cheap unit with no spares access does not.

When a GC fails mid-campaign, the question is not who sold it but who can be at the plant tomorrow. Before purchase, ask a supplier these specific questions: where are the service engineers based, what is the committed response time, which spare parts are stocked in India (EPC modules, igniters, FID jets, inlet assemblies, headspace needles and seals), and is remote diagnostic support available? Ask also whether the supplier will supply the OEM-specification parts rather than substitutes, since a compliance file is easier to defend when parts are traceable.

Many units in Hyderabad run two shifts or more, so keep a small on-site kit of consumables and a plan for method continuity. A second validated GC, even an older one, gives you the ability to continue release testing during repairs and to run confirmation methods on a different column without queuing.

1.           Write the user requirement specification: analytes, limits, sample throughput, detectors, sampler and software.

2.           Confirm the instrument platform and model are supported with spares in India for the coming five to seven years.

3.           Ask for the refurbishment report: what was inspected, replaced and tested, and with which reference standards.

4.           Request a demonstration or test chromatogram showing noise, drift, retention time repeatability and peak area precision.

5.           Verify the carrier gas and detector gas configuration (EPC modules, gas types, pressure ranges) against your gas strategy.

6.           Check headspace performance independently, including carryover and vial pressurisation stability.

7.           Review the CDS version, licensing, operating system support and audit trail capability.

8.           Obtain written warranty terms, response times and the list of excluded parts.

9.           Agree who performs IQ/OQ and which documents you receive for your validation file.

10.       Plan the physical installation: bench, ventilation, gas lines, power backup and exhaust.

11.       Define the method transfer plan and acceptance criteria before the system arrives.

Schedule analyst training and decide on a preventive maintenance calendar from day one.